HOME >> BIOLOGY >> NEWS
Purdue engineers develop quick, inexpensive method to prototype microchips

WEST LAFAYETTE, Ind. - Purdue University researchers have developed a new method to quickly and inexpensively create microfluidic chips, analytic devices with potential applications in food safety, biosecurity, clinical diagnostics, pharmaceuticals and other industries.

"This development democratizes the preparation of microfluidic biochips," said Michael Ladisch, Distinguished Professor of Agricultural and Biological Engineering and Biomedical Engineering. "This brings the design and manufacture of these devices within reach of scientists in many laboratories who can now easily test their ideas and conduct research within a typical laboratory setting."

Microfluidics is a branch of nanotechnology that involves manipulating minute quantities of liquids, typically in a chip device approximately the size of a postage stamp. The initial design and manufacture of these chips often requires weeks of work, but the new approach developed by Ladisch and Tom Huang, a graduate student in chemical engineering, cuts that time to hours.

Microchips have traditionally been made through a lengthy and expensive process called photolithography, which uses X-rays or ultraviolet light to form a pattern on a glass or silicon wafer that is then etched by washing the wafer with a variety of solvents. The key to controlling the shape and size of the patterns on the wafer is the production of a template, which can take weeks to develop.

Ladisch and his team have developed an alternative method that uses materials easily acquired by any research laboratory, including glass microscope slides, tweezers, thin glass fibers such as those found in glass wall insulation, and a flexible polymer called PDMS that is available from most scientific supply companies.

"What we've done is really thinking outside of the box," said Nate Mosier, an assistant professor of agricultural and biological engineering who also contributed to this project. "This is a rad
'"/>

Contact: Jennifer Cutraro
jcutraro@purdue.edu
765-496-2050
Purdue University
7-Jan-2004


Page: 1 2 3

Related biology news :

1. Purdue study finds antioxidant protects metal-eating plants
2. Bright idea could doom cancer and viruses, say Purdue scientists
3. Purdue yeast makes ethanol from agricultural waste more effectively
4. IU and Purdue scientists to answer questions about Brood X periodical cicadas
5. Purdue scientists finding ways to outsmart crop-damaging bugs
6. Chestnut trees to spread across landscape again, says Purdue scientist
7. Purdue scientists: To stop cancer, keep your Icmt away from your Ras
8. Purdue chemists put the twist on protein building block
9. Purdue scientists: Genetically modified fish could damage ecology
10. Fat cells fight disease, Purdue University researchers find
11. Purdue chemist mussels in on secrets of natural adhesives

Post Your Comments:
(Date:6/19/2013)... 2012, the European Medicines Agency (EMA) approved the ... ever gene therapy for clinical use in the ... developed AAV-LPL S447X for the treatment of a ... (LPLD) which affects approximately one or two out ... life-threatening inflammations of the pancreas. Afflicted individuals carry ...
(Date:6/18/2013)... awarded a $394,300 grant from the Tarrant Regional ... in the new facilities of the 150-mile Integrated ... professor of civil engineering, will investigate the best ... water in an effort to eliminate biological growths ... monochloramine is widely practiced throughout the United States. ...
(Date:6/18/2013)... June 18, 2013 Joshua Obar, Ph.D., Department ... been honored with a 2013 ICAAC Young Investigator Award ... of immunological memory responses to infection. , Obar ... in 2001 and went on to complete his Ph.D. ... He performed his Ph.D. thesis research in Edward ...
Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2The American Society for Microbiology honors Joshua Obar 2
(Date:6/19/2013)... Calif. , June 19, 2013  Continuing its ... myocardial infarction (MI), Beckman Coulter , Inc. announces ... of its new Access AccuTnI+3 troponin I assay for ... "Clinicians have depended on Beckman Coulter,s ... new AccuTnI+3 assay has the proven performance to continue ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Today DuPont ... young people to become leaders in the greatest challenge ... billion people in 2050. Borel spoke at the ... Conference in Atlanta, about urgent need for students to ... are local, science-based, sustainable and reached in collaboration with ...
(Date:6/19/2013)... 2013 BioConvergence team members Curtis ... at 2013’s BioLogistics Summit in San Francisco earlier ... Cold Chain IQ and IQPC, addressed the increasingly ... in part, attributed to current trends of globalization, ... these trends is an increase in movement, which ...
(Date:6/19/2013)... June 18, 2013 A new look ... costs and other trends will highlight technical sessions at ... this fall. In its 33rd year, the three-day event ... exhibition of key suppliers, approximately 100 technical presentations and ... the international society for optics and photonics , the ...
Breaking Biology Technology:Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3DuPont Leader Calls for New Generation of Food Visionaries to Fight Hunger 2BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3
Cached News: